Kenner Family Research Fund (KFRF) is entering its third year of committed activities to develop an early detection protocol for pancreatic cancer. We are more optimistic now than we have ever been about the future of this field. Just as significant progress has been made in the early detection and subsequent treatment for breast, colon, and prostate cancers we know that advancements are forthcoming for individuals diagnosed with pancreatic cancer. Each year KFRF has expanded its leadership role in creating opportunities for experts in interprofessional fields to collaborate in strategic innovation and research.
- Barbara Kenner, PhD, Founder

      Board of Directors

      Barbara Kenner, Ph.D., Founder
      Nicholas Kenner
      Ashley Stark Kenner
      Kate Kenner Archibald
      Samuel Archibald
      Ann Goldberg
      Laura Rothschild
      Richard Summer

    KFRF is laser focused on the development of early detection screening methods that will improve the options for treatment and quality of life for those with pancreatic cancer. The progress made in the identification of early prostate, colon, and breast cancers serve as a model for achievement.
- Nick Kenner, Board of Directors

      Scientific Advisors

      Suresh T. Chari, M.D., F.A.C.G.
      Professor of Medicine
      College of Medicine, Mayo Clinic
      Consultant, Division of Gastroentrerology and Hespatology
      Department of Internal Medicine
      Mayo Medical Center

      Bruce F. Field
      Principal Engineer
      Technology & Advanced Products

      Vay Liang W. Go, M.D.
      Professor of Medicine,
      David Geffen School of Medicine at UCLA
      Director, UCLA Center for Excellence in Pancreatic Disease Research
      Editor-in-Chief, Pancreas

      David S. Klimstra, M.D.
      Department of Pathology
      Memorial Sloan-Kettering Cancer Center

      Richard R. P. Warner, M.D.
      Professor of Medicine
      Director of Center for Carcinoid and Neuroendocrine Tumors
      The Mount Sinai School of Medicine